These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4099609)

  • 1. Jaundice of the newborn and phenobarbitone.
    Lancet; 1971 Jan; 1(7690):119-20. PubMed ID: 4099609
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis of neonatal hyperbilirubinemia with phenobarbital.
    Halpin TF; Jones AR; Bishop HL; Lerner S
    Obstet Gynecol; 1972 Jul; 40(1):85-90. PubMed ID: 4625595
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenobarbitone prophylaxis for neonatal hyperbilirubinemia.
    Yeung CY; Tam LS; Chan A; Lee KH
    Pediatrics; 1971 Sep; 48(3):372-6. PubMed ID: 5094338
    [No Abstract]   [Full Text] [Related]  

  • 4. The management of jaundice in the newborn.
    Grauaug A
    Med J Aust; 1972 Aug; 2(7):374-7. PubMed ID: 4673403
    [No Abstract]   [Full Text] [Related]  

  • 5. Changing concepts regarding exchange transfusions and neonatal jaundice.
    Lucey JF
    Clin Obstet Gynecol; 1971 Jun; 14(2):586-93. PubMed ID: 4938514
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conservative methods of control of hyperbilirubinemia in newborn infants (review of the literature)].
    Punchenok NA
    Vopr Okhr Materin Det; 1968 May; 13(5):60-3. PubMed ID: 4888517
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect on neonatal hyperbilirubinemia of phenobarbital during pregnancy or after birth: practical value of the treatment in a population with high risk of unexplained severe neonatal jaundice.
    Valaes T; Petmezaki S; Doxiadis SA
    Birth Defects Orig Artic Ser; 1970 Jun; 6(2):46-54. PubMed ID: 4941650
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy in the prevention of transitory hyperbilirubinemia in premature newborn infants].
    Reineke J
    ZFA (Stuttgart); 1976 May; 52(13):681-2. PubMed ID: 1274416
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of transitory hyperbilirubinemia of the premature and mature newborn infants and of the hemolytic disease of the newborn by an enzyme induction combination: phenobarbital-nikethamide].
    Kintzel HW; Schwarze R; Hinkel GK
    Schweiz Med Wochenschr; 1972 Sep; 102(38):1339-45. PubMed ID: 4630163
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of newborn infant hyperbilirubinemia by use of drugs. 8. Recommendation for the use of prevention in combination with a screening test for prognosis].
    Gmyrek D; Bunke H; Cario WR; Daberkow H; Läuter J; Saworra H; Weh L; Syllm-Rapoport I
    Kinderarztl Prax; 1973 Apr; 41(4):174-90. PubMed ID: 4731678
    [No Abstract]   [Full Text] [Related]  

  • 11. CNS abnormalities after hyperbilirubinemia.
    JAMA; 1969 May; 208(5):856. PubMed ID: 5818590
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenobarbital and neonatal jaundice. The need for more knowledge.
    Sisson TR
    Clin Pediatr (Phila); 1971 Dec; 10(12):683-4. PubMed ID: 4334543
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled trials of phenobarbitone therapy of neonatal jaundice.
    Ramboer C; Thompson RP; Williams R
    Lancet; 1969 May; 1(7602):966-8. PubMed ID: 4180816
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of hyperbilirubinemia in premature infants using a combination of two enzyme inductors: phenobarbitol and nikethamide].
    Hinkel GK; Kintzel HW; Schwarze R; Händel A
    Dtsch Gesundheitsw; 1972 Sep; 27(39):1854-7. PubMed ID: 4634399
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperbilirubinemia in premature infants during 1948-1973 (evaluation and therapy of physiological jaundice in newborn infants of low birth weight during the past 25 years)].
    Török J
    Orv Hetil; 1973 Aug; 114(31):1847-53. PubMed ID: 4579672
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenobarbital prophylaxis of neonatal hyperbilirubinemia. Evaluation of a nightly dose.
    Thomas CR
    Obstet Gynecol; 1977 Nov; 50(5):607-10. PubMed ID: 909669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine phenobarbital for prevention of neonatal hyperbilirubinemia.
    Thomas CR
    Obstet Gynecol; 1976 Mar; 47(3):304-8. PubMed ID: 1250562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal pathologic jaundice: seven to nine years follow-up.
    Rosta J; Makói Z; Békefi D; Popper P; Szinetár S; Szegö L; Szabó M; Szendröi M; Ribári O
    Acta Paediatr Acad Sci Hung; 1971; 12(3):317-21. PubMed ID: 5169922
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of neonatal jaundice with phenobarbitone.
    Ramboer C; Thompson RP; Williams R
    Gut; 1969 May; 10(5):414. PubMed ID: 4890538
    [No Abstract]   [Full Text] [Related]  

  • 20. Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment.
    Trolle D
    Lancet; 1968 Sep; 2(7570):705-8. PubMed ID: 4175089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.